Medical Device Testing Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Medical Device Testing Market in 2025 is assessed at USD 10.49 billion. The global Market size was valued at around USD 10.05 billion in 2024 and is projected to grow at a CAGR of more than 5.5%, reaching USD 20.16 billion revenue by 2037. Asia Pacific is poised to yield USD 7.06 billion by 2037, driven by large geriatric population and the rising prevalence of chronic diseases leading to higher demand for medical devices.
Consumers repeatedly are demanding effectiveness, outstanding performance, and security from medical devices. This factor has raised the demand for the verification and validation of medical devices. Therefore, it is compulsory for manufacturers to properly define and test medical devices for confirmation of quality. The government authorities of various regions have mandated the medical testing procedure for medical devices before their use.
Advancement in technology such as the adoption 0f AI or IoT in multiple medical devices is expected to create lucrative growth opportunities for the sector. Various companies are now incorporating these technologies into their devices. Innovative and advanced medical devices aid in accurate results of disease diagnosing invention in medical devices and also offers cost-friendly technology-based therapeutic tools for disease treatment. Various government authorities and companies do promote medical research centers. In 2021, PaxeraHealth declared that it had established an AI-based imagining platform in the United States
Medical Device Testing Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Demand for Medical Devices – As the utilization of medical devices grows, consumers start demanding devices that ensure safe, and effectiveness and meet regulatory requirements. This attribute has boosted the growth in the medical device testing market, as market players now offering testing services and equipment to ensure the quality of medical devices. As per the statistics, the revenue in the Medical Devices segment reached a value of USD 480 billion in 2021.
- Growing Geriatric Population Globally – As the geriatric population increases, the demand for various medical devices also seems to grow owing to the demand for treatment of aged people suffering from various health conditions and diseases. This has increased the invention of innovative and advanced medical devices as well as raised the focus on ensuring that these devices are effective and safe with the help of rigorous testing methods. By 2030, 1 in 6 people is estimated to be over the age of 60 years old. An estimated 2.1 billion people are anticipated to be above the age of 60 or under the geriatric population by 2050 globally.
- Growing Complexity in Medical Devices – The complexities in medical devices are growing day by day, which is expected to drive the need for specialized testing services and devices. As medical devices become complex the testing needed for the medical equipment to check their safety and effectiveness becomes complex which raises the demand for medical device testing.
- A surge in Demand for In-Vitro Tests – Medical device testing is used in In-vitro diagnostics to detect various harmful health conditions such as HIV, malaria, hepatitis, and others. It is tested on human body samples such as on blood or tissue.
Challenges
- High Initial Investment – Medical device testing involves high initial investment, especially in terms of complex devices that need extensive testing. This can emerge as a barrier in front of this market in the upcoming times.
- Strict Regulations on Medical Device Standards
- Rapidly Changing Technology
Medical Device Testing Landscape: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.5% |
|
Base Year Market Size (2024) |
USD 10.05 billion |
|
Forecast Year Market Size (2037) |
USD 20.16 billion |
|
Regional Scope |
|
Medical Device Testing Segmentation
Services (Testing, Inspection, Certification)
Testing segment is expected to account for remarkable medical device testing market share by the end of 2037. The testing segment is high in demand in the medical device testing market owing to increased demand for advanced products, awareness among consumers, and high-quality products. The testing service aids in reducing the cost of the pre-production phase along with this it enhances the marketability of medical devices.
Moreover, in response to the urgent demands of patients and healthcare systems around the world dealing with COVID-19. Medtronic PLC announced in March 2020 that it had increased production by more than 40% to date and was on track to more than double its capacity to manufacture and supply ventilators.
End-User (Hospitals, Research Centers, Homecare Clinics)
The hospital segment is predicted to hold 38% share of the global medical device testing market in the projected period. Hospitals use all types of medical devices from simple diagnostic devices to complex ones, and these devices must be checked and verified before use to ensure their safety and effectiveness.
Our in-depth analysis of the global market includes the following segments:
|
Services |
|
|
Technology |
|
|
Application |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Medical Device Testing Industry - Regional Synopsis
APAC Market Forecast
Asia Pacific industry is expected to account for largest revenue share of 35% by 2037, attributed to the large geriatric population in countries, such as India and China. As the old population rises in the region prevalence of chronic and other kinds of diseases grows leading to the major demand for medical devices and medical device testing.
Moreover, improving healthcare facilities, along with rising health awareness amongst the people, are projected to boost the market growth.
North American Market Statistics
The North American medical device testing market is poised to gain the largest market share throughout the projected period. The regional growth is ascribed to the high investment in testing activities, along with increasing investment in R&D activities in the region. The American Medical Association estimates that the United States spent USD 4.3 trillion, or USD 12.914 per person, on healthcare in 2021.
Additionally, as more medical devices are approved in the area, rising demand for medical device testing services may promote market expansion.
Companies Dominating the Medical Device Testing Landscape
- Intertek Group PLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- SGS S.A.
- TUV Rheinland Group
- Eurofins Scientific
- Cordant Health Solutions
- Legacy Medical Services, LLC
- Omega Laboratories, Inc.
- GE Healthcare
- Thermo Fisher Scientific, Inc.
- Siemens AG
Recent Developments
- Eurofins Scientific and Transgenic Inc. Acquired Genetic Lab Co., Ltd. To establish a network of clinical diagnostics laboratories in Asia.
- Intertek expanded its business to personal protective equipment services, including respirator precertification testing after COVID-19.
Author Credits: Radhika Pawar
- Report ID: 3866
- Published Date: May 08, 2025
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Medical Device Testing Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
